Literature DB >> 10536042

A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality.

K W Marek1, I K Vijay, J D Marth.   

Abstract

Formation of the dolichol oligosaccharide precursor is essential for the production of asparagine- (N-) linked oligosaccharides (N-glycans) in eukaryotic cells. The first step in precursor biosynthesis requires the enzyme UDP-GlcNAc: dolichol phosphate N-acetylglucosamine-1-phosphate transferase (GPT). Without GPT activity, subsequent steps necessary in constructing the oligosaccharide precursor cannot occur. Inhibition of this biosynthetic step using tunicamycin, a GlcNAc analog, produces a deficiency in N-glycosylation in cell lines and embryonic lethality during preimplantation development in vitro, suggesting that N-glycan formation is essential in early embryogenesis. In exploring structure-function relationships among N-glycans, and since tunicamycin has various reported biochemical activities; we have generated a germline deletion in the mouse GPT gene. GPT mutant embryos were analyzed and the phenotypes obtained were compared with previous studies using tunicamycin. We find that embryos homozygous for a deletion in the GPT gene complete preimplantation development and also implant in the uterine epithelium, but die shortly thereafter between days 4-5 postfertilization with cell degeneration apparent among both embryonic and extraembryonic cell types. Of cells derived from these early embryos, neither trophoblast nor embryonic endodermal lineages are able to survive in culture in vitro. These results indicate that GPT function is essential in early embryogenesis and suggest that N-glycosylation is needed for the viability of cells comprising the peri-implantation stage embryo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10536042     DOI: 10.1093/glycob/9.11.1263

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  42 in total

1.  The clinical relevance of glycobiology.

Authors:  H Schachter
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Human plasma glycome in attention-deficit hyperactivity disorder and autism spectrum disorders.

Authors:  Nela Pivac; Ana Knezević; Olga Gornik; Maja Pucić; Wilmar Igl; Hilde Peeters; An Crepel; Jean Steyaert; Mislav Novokmet; Irma Redzić; Matea Nikolac; Vesna Novković Hercigonja; Katarina Dodig Curković; Mario Curković; Gordana Nedić; Dorotea Muck-Seler; Fran Borovecki; Igor Rudan; Gordan Lauc
Journal:  Mol Cell Proteomics       Date:  2010-10-25       Impact factor: 5.911

3.  Improvement of dolichol-linked oligosaccharide biosynthesis by the squalene synthase inhibitor zaragozic acid.

Authors:  Micha A Haeuptle; Michael Welti; Heinz Troxler; Andreas J Hülsmeier; Timo Imbach; Thierry Hennet
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

4.  A defect in dolichol phosphate biosynthesis causes a new inherited disorder with death in early infancy.

Authors:  Christian Kranz; Christoph Jungeblut; Jonas Denecke; Anne Erlekotte; Christina Sohlbach; Volker Debus; Hans Gerd Kehl; Erik Harms; Anna Reith; Sonja Reichel; Helfried Grobe; Gerhard Hammersen; Ulrich Schwarzer; Thorsten Marquardt
Journal:  Am J Hum Genet       Date:  2007-01-31       Impact factor: 11.025

5.  DPAGT1 myasthenia and myopathy: genetic, phenotypic, and expression studies.

Authors:  Duygu Selcen; Xin-Ming Shen; Joan Brengman; Ying Li; Anthony A Stans; Eric Wieben; Andrew G Engel
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

6.  NgBR is essential for endothelial cell glycosylation and vascular development.

Authors:  Eon Joo Park; Kariona A Grabińska; Ziqiang Guan; William C Sessa
Journal:  EMBO Rep       Date:  2016-01-11       Impact factor: 8.807

Review 7.  Metabolic manipulation of glycosylation disorders in humans and animal models.

Authors:  Hudson H Freeze; Vandana Sharma
Journal:  Semin Cell Dev Biol       Date:  2010-04-02       Impact factor: 7.727

Review 8.  Mouse models for congenital disorders of glycosylation.

Authors:  Christian Thiel; Christian Körner
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

9.  A compound heterozygous mutation in DPAGT1 results in a congenital disorder of glycosylation with a relatively mild phenotype.

Authors:  Zafar Iqbal; Mohsin Shahzad; Lisenka E L M Vissers; Monique van Scherpenzeel; Christian Gilissen; Attia Razzaq; Muhammad Yasir Zahoor; Shaheen N Khan; Tjitske Kleefstra; Joris A Veltman; Arjan P M de Brouwer; Dirk J Lefeber; Hans van Bokhoven; Sheikh Riazuddin
Journal:  Eur J Hum Genet       Date:  2012-12-19       Impact factor: 4.246

Review 10.  Aberrant PSA glycosylation--a sweet predictor of prostate cancer.

Authors:  Sarah Gilgunn; Paul J Conroy; Radka Saldova; Pauline M Rudd; Richard J O'Kennedy
Journal:  Nat Rev Urol       Date:  2013-01-15       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.